Identity
- Trade Name
- silverfox FDA UDI
- Generic Name
- Multi-modality physical therapy system, professional-use FDA UDI
- Model / Reference
- F-825 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 06973134771266 FDA UDI
- FDA Product Code
- ISA FDA UDI
- GMDN Term
- Multi-modality physical therapy system, professional-use FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 890.5660 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Multi-modality physical therapy system, professional-use
silverfox by Silver Fox Corporation Limited — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multi-modality physical therapy system, professional-use.
- Dynatron 25 Series 525B — Dynatronics Corp. · Class II
- Dynatron Solaris Plus 708 — Dynatronics Corp. · Class II
- RAYJU — Hunan Ruijiu Technology Co., Ltd. · Class II
- WINBACK — WINBACK GO EAST · Class II
- BlueOnyx Pro — Tama Research Corporation · Class II
- STAR — ELETTRONICA PAGANI SRL · Class I
- BlackOnyx — Tama Research Corporation · Class II
- Winback Back 3SE — Daeyang Medical Co., Ltd. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Silver Fox Corporation Limited
Sources (1)
- FDA UDI 3486df3a-18d8-4267-8226-66b3418bfb62 32 fields · synced Jun 8, 2026